Development and validation of a stability indicating RP-UPLC method for determination of quetiapine in pharmaceutical dosage form

Scientia Pharmaceutica

Volumn 79, Issue 1, 2011, Pages 97-111

  Trivedi, Rakshit Kanubhai ^a,b   Patel, Mukesh C ^b  

^a DR REDDY'S LABORATORIES LTD   (India)

^b PS Science and HDPatel Arts College   (India)

Author keywords

Assay; Chromatography; Degradation products; Method validation; Rapid; Seroque

Indexed keywords

ACETONITRILE; METHANOL; QUETIAPINE; SOLVENT; TRIETHYLAMINE;

ACCURACY; ARTICLE; CHROMATOGRAPHY; DEGRADATION KINETICS; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG STABILITY; DRUG STRUCTURE; ELUTION; PH MEASUREMENT; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION; VALIDATION STUDY;

EID: 79952925133     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1009-12     Document Type: Article

References (27)

1. Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG. Quetiapine in patients with schizophrenia. A high-and low-dose double-blind comparison with placebo. Seroquel study group. Arch Gen Psychiatry. 1997; 54: 549-557. PMid:9193196
2. DeVane CL, Nemeroff CB. Clinical pharmacokinetics of Quetiapine-An atypical antipsychotic. Clin Pharmacokinet. 2001; 40: 509-522. PMid:11510628
3. http://www.rxlist.com/cgi/generic2/quetiappi.htm, 2003, p. 31.
4. Seroquel™, Summary of product characteristics. AstraZeneca UK Limited. 2003; Vol. 23.
5. International Conference on Harmonization (ICH). Stability Testing of New Drug Substances and Products, Q1A (R2), IFPMA, Geneva, Switzerland, 2003.
6. Radha Krishna S, Rao BM, Someswara Rao N. A validated stability indicating HPLC method for the determination of related substances in quetiapine fumarate. Rasayan J Chem. 2008; 3: 466-474.
7. Belal F, Elbrashy A, Eid M, Nasr JJ. Stability-Indicating HPLC method for the determination of quetiapine: Application to tablets and human plasma. J Liq Chrom Rel Technol. 2008; 31: 1283-1298. doi:10.1080/10826070802019681
8. Pucci V, Mandrioli R, Ferranti A, Furlanetto S, Augusta Raggi M. Quality control of commercial tablets containing the novel antipsychotic quetiapine. J Phar Biom Anal. 2003; 32: 1037-1044. doi:10.1016/S0731-7085(03)00206-1
9. El-Enany N, El-Brashy A, Belal F, El-Bahay N. Polarographic analysis of quetiapine in pharmaceuticals. Port Electrochim Acta. 2009; 27: 113-125. doi:10.4152/pea.200902113
10. Dhaneshwar SR, Patre NG, Mahadik MV. Stability-indicating HPTLC method for quantitation of quetiapine fumarate in the pharmaceutical dosage form. Acta Chromatogr. 2009; 21: 83-93. doi:10.1556/AChrom.21.2009.1.7
11. Hillaert S, Snoeck L, Van den Bossche W. Optimization and validation of a capillary zone electrophoretic method for the simultaneous analysis of four atypical antipsychotics. J Chromatogr A. 2004; 1033: 357-362. doi:10.1016/j.chroma.2004.01.057
12. Ozkan SA, Dogan B, Uslu B. Voltammetric analysis of the novel atypical antipsychotic drug quetiapine in human serum and urine. Microchim Acta. 2006; 153: 27-35. doi:10.1007/s00604-005-0457-x
13. Pullen RH, Palermo KM, Curtis MA. Determination of an antipsychotic agent (ICI 204, 636) and its 7-hydroxy metabolite in human plasma by high performance liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr. 1992; 573: 49-57. PMid:1348747
14. Davis PC, Bravo O, Gehrke M, Azumaya CT. Development and Validation of an LC-MS method for the determination of quetiapine and four related metabolites in human plasma. J Phar Biom Anal. 2010; 51: 1113-1119. doi:10.1016/j.jpba.2009.11.018
15. Mandrioli R, Fanali S, Ferranti A, Raggi MA. HPLC analysis of the novel antipsychotic drug quetiapine in human plasma. J Pharm Biomed Anal. 2002; 30: 969-977. doi:10.1016/S0731-7085(02)00395-3
16. Hasselstrom J, Linnet K. Fully automated on-line quantification of quetiapine in human serum by solid phase extraction and liquid chromatography. J Chromatogr B. 2003; 798: 9-16. doi:10.1016/S1570-0232(03)00592-0
17. Li K-Y, Zhou Y-G, Ren H-Y, Wang F, Zhang B-K, Li H-D. Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of atypical antipsychotics and some metabolites in in vivo sample. J Chromatogr B. 2007; 850: 581-585. doi:10.1016/j.jchromb.2006.12.051
18. J Sachse J, Köller J, Härtter S, Hiemke C. Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performanceliquid chromatography with column-switching and spectrophotometric detection. J Chromatogr B. 2006; 830: 342-348. doi:10.1016/j.jchromb.2005.11.032
19. Zhou Z, Li X, Li K, Xie Z, Cheng Z, Peng W, Wang F, Zhu R, Li H. Simultaneous determination of clozapine, olenzapine, risperidone and quetiapine in plasma by highperformance liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B. 2004; 802: 257-262. doi:10.1016/j.jchromb.2003.11.037
20. Saracino MA, Mercolini L, Flotta G, Albers LJ, Merli R, Raggi MA. Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high-performance liquid chromatography. J Chromatogr B. 2006; 843: 227-233. doi:10.1016/j.jchromb.2006.06.001
21. Kirchherr H, Kühn-Velten WN. Quantitative determination of forty eigth antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: A multi-level, single-sample approach. J Chromatogr B. 2006; 843: 100-113. doi:10.1016/j.jchromb.2006.05.031
22. Mercolini L, Grillo M, Bartoletti C, Boncompagni G, Raggi MA. Simultaneous analysis of classical neuroleptics, atypical antipsychotics and their metabolites in human plasma. J Anal Bioanal Chem. 2007; 388: 235-243. doi:10.1007/s00216-007-1195-1
23. Barrett B, Holcapek M, Huclová J, Borek-Dohalský V, Fejt P, Nemec B, Jelínek I. Validated HPLC-MS-MS method for determination of quetiapine in human plasma. J Pharm Biomed Anal. 2007; 44: 498-505. doi:10.1016/j.jpba.2007.03.034
24. Stolarczyk EU, Kaczmarek L, Eksanow K, Kubiszewski M, Glice M, Kutner A. Identification and characterization of potential impurities of quetiapine fumarate. Pharm Dev Technol. 2009; 14: 29-39. PMid:18815940
25. Bharathi Ch, Prabahar KJ, Prasad ChS, Srinivasa Rao M, Trinadhachary GN, Handa VK, Dandala R, Naidu A. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate. Pharmazie. 2008; 63: 9-14. doi:10.1691/ph.2008.7174
26. ICH harmonized tripartite guideline. Impurities in New Drug products Q3B(R2), current step 4 version dated 2 June 2006.
27. ICH, Validation of Analytical Procedure, Text and Methodology Q2(R1), International conference on Harmonization, IFPMA, Geneve, Switzerland, 2005.